Schubert & Co’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-36
Closed -$1.28K 1651
2023
Q1
$1.28K Buy
36
+9
+33% +$327 ﹤0.01% 1097
2022
Q4
$990 Buy
27
+23
+575% +$909 ﹤0.01% 1182
2022
Q3
$0 Sell
4
-32
-89% -$2.07K ﹤0.01% 1642
2022
Q2
$3K Buy
36
+23
+177% +$1.68K ﹤0.01% 687
2022
Q1
$1K Sell
13
-7
-35% -$592 ﹤0.01% 1023
2021
Q4
$2K Buy
+20
New +$1.92K ﹤0.01% 482

Other funds holding SYNH

Schubert & Co's SYNH Position: Q2 2023 in Review

Schubert & Co sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 36 shares — an estimated $1.28K sold.

Schubert & Co first reported a position in SYNH in Q4 2021 and held it in 6 quarters. The position peaked at $3K in Q2 2022. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Schubert & Co reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 36 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $1.28K.
  • Schubert & Co first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Syneos Health, Inc. Class A Common Stock position peaked at $3K in Q2 2022.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.